0001493152-22-024449.txt : 20220831 0001493152-22-024449.hdr.sgml : 20220831 20220831092016 ACCESSION NUMBER: 0001493152-22-024449 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220831 DATE AS OF CHANGE: 20220831 EFFECTIVENESS DATE: 20220831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANGOCEUTICALS, INC. CENTRAL INDEX KEY: 0001938046 IRS NUMBER: 873841292 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457534 FILM NUMBER: 221216456 BUSINESS ADDRESS: STREET 1: 4131 N. CENTRAL EXPRESSWAY, SUITE 900 CITY: DALLAS STATE: TX ZIP: 75204 BUSINESS PHONE: (833) 626-4679 MAIL ADDRESS: STREET 1: 4131 N. CENTRAL EXPRESSWAY, SUITE 900 CITY: DALLAS STATE: TX ZIP: 75204 D 1 primary_doc.xml X0708 D LIVE 0001938046 MANGOCEUTICALS, INC. 4131 N. CENTRAL EXPRESSWAY SUITE 900 DALLAS TX TEXAS 75204 (833) 626-4679 TEXAS None None Corporation true 2021 Jacob Cohen 4131 N. Central Expressway Suite 900 Dallas TX TEXAS 75204 Executive Officer Director Jonathan Arango 4131 N. Central Expressway Suite 900 Dallas TX TEXAS 75204 Executive Officer Director Other Decline to Disclose 06b false 2022-08-16 false true true false 50000 Boustead Securities, LLC 141391 None None 6 VENTURE SUITE 395 IRVINE CA CALIFORNIA 92618 AZ ARIZONA CA CALIFORNIA FL FLORIDA NV NEVADA NY NEW YORK TX TEXAS false 2000000 400000 1600000 false 4 57000 0 Includes 1% non-accountable expense. Does not include warrants to purchase 7% of the shares and warrants sold in the offering also granted to the placement agent. 20000 true false MANGOCEUTICALS, INC. /s/ Jacob Cohen Jacob Cohen CEO 2022-08-31